Short answer · Medically reviewed summary · Last updated: 2026-04-07
Saethre-Chotzen syndrome is an ultra-rare genetic disorder with an estimated prevalence of approximately 1 in 25,000 to 1 in 50,000 live births. While exact global numbers are difficult to track due to potential underdiagnosis, it is recognized as a leading cause of craniosynostosis worldwide. What is the estimated prevalence and incidence of Saethre-Chotzen syndrome? The prevalence of Saethre-Chotzen syndrome is generally cited in medical literature as ranging between 1 in 25,000 and 1 in 50,000 individuals.
Saethre-Chotzen syndrome is an ultra-rare genetic disorder with an estimated prevalence of approximately 1 in 25,000 to 1 in 50,000 live births. While exact global numbers are difficult to track due to potential underdiagnosis, it is recognized as a leading cause of craniosynostosis worldwide.
The prevalence of Saethre-Chotzen syndrome is generally cited in medical literature as ranging between 1 in 25,000 and 1 in 50,000 individuals. Because this condition is a genetic disorder caused by mutations in the TWIST1 gene, incidence is stable across populations and does not typically show significant geographic or ethnic clustering. It is classified as a rare disease, and because some individuals may present with very mild physical features—such as subtle facial asymmetry or minor limb abnormalities—it is widely believed that the actual number of people living with Saethre-Chotzen syndrome may be higher than current clinical registries suggest.
Saethre-Chotzen syndrome affects males and females with equal frequency, as the underlying TWIST1 gene mutation is located on an autosome (chromosome 7) rather than a sex chromosome. Regarding age of onset, the condition is congenital, meaning it is present at birth. However, the diagnosis of Saethre-Chotzen syndrome often occurs in the pediatric years when craniosynostosis (the premature fusion of skull bones) becomes clinically apparent. While the physical manifestations are lifelong, adults with milder forms of the syndrome may only be diagnosed after having a child with more severe symptoms, highlighting the variable expressivity of the condition.
Accurate epidemiological data for Saethre-Chotzen syndrome is hampered by several factors, including:
Current clinical data is bolstered by the lived experience of patients and families. Within the DiseaseMaps.org platform, 48 people with Saethre-Chotzen syndrome have joined the community to share their experiences. This real-world patient data provides a vital perspective that complements formal medical statistics, helping researchers understand the day-to-day challenges, diagnostic journeys, and long-term outcomes for those living with Saethre-Chotzen syndrome across the globe.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of a physician or other qualified health provider with any questions regarding a medical condition.